Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2005
03/16/2005CN1594574A Sea anemone neurotoxin gene Sr2 and application thereof
03/16/2005CN1594573A Sea anemone neurotoxin gene Sr1 and application thereof
03/16/2005CN1594572A Sea anemone neurotoxin gene Sr7 and application thereof
03/16/2005CN1594571A Paraquat resistance gene and a vascular tissue- and trichome-specific promotor
03/16/2005CN1594570A Protein coded sequence of protein kinase 1 activated by Brassica napus L. cell mitogen
03/16/2005CN1594569A Protein coded sequence of protein kinase 9 activated by Brassica napus L. cell mitogen
03/16/2005CN1594567A Immune tbid gene, encoded protein and use thereof
03/16/2005CN1594360A Red cashew nut legumin and its preparation and use
03/16/2005CN1594359A Hepatitis B vaccine and its preparation method
03/16/2005CN1594348A T cell receptor sequence and method for detecting and treating rheumatoid arthritis
03/16/2005CN1193098C Method of hybrid seed production using conditional female sterility
03/16/2005CN1193095C Complex
03/16/2005CN1193094C Antigenic proteins of shrimp white spot syndrome virus and uses thereof
03/16/2005CN1193043C Stabilized denatured lipoprotein and process for producing the same
03/16/2005CN1193042C C-peptide for the improved production of insulin and insulin analogues
03/16/2005CN1193041C New human protein with the function of inhibiting cancer cell growth and its encoding sequence
03/16/2005CN1193040C New human protein with the function of inhibiting tumor cell growth and its encoding sequence
03/16/2005CN1192799C Adjuvant combination formulations
03/16/2005CN1192798C Vaccine
03/15/2005US6867353 Production method of recombinant rotavirus structural proteins and vaccine composition
03/15/2005US6867351 Protein kinase stress-related proteins and methods of use in plants
03/15/2005US6867348 Methods and compositions for screening for angiogenesis modulating compounds
03/15/2005US6867292 Characterization of novel gene cbl-SL
03/15/2005US6867291 Human hemicentin proteins and polynucleotides encoding the same
03/15/2005US6867288 Polycystic kidney disease gene
03/15/2005US6867197 Method of targeting conjugate molecules to mitochondria
03/15/2005US6867195 In vivo translation delivering antisense nucleotides; elicit-ing immune response to poorly immunogenic viral proteins
03/15/2005US6867186 Anticancer agents
03/15/2005US6867181 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
03/15/2005US6867180 Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth
03/15/2005US6867177 CD39/ECTO-adpase as a treatment for thrombotic and ischemic disorders
03/15/2005US6867042 Generating/measuring improved polypeptide solubility in vitro/in situ using reporter molecule and mutagenesis
03/15/2005US6867037 High level secretory expression system of intact MK family protein
03/15/2005US6867033 By administration of PV virus-like particles (VLPs) to a patient suffering from the PV infection
03/15/2005US6867020 Nucleotide sequences coding preferential polypeptides associated with blood formation; for use in treatment of blood disorders
03/15/2005US6867019 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
03/15/2005US6867018 Enzyme and enzymatic procedures for cleaving the beta secretase cleavage site of the amyloid protein precursor (APP) and associated nucleic acids, peptides, vectors, cells and cell isolates and assays for identifying drug candidates
03/15/2005US6867017 ATP-binding transporter (ABC7) and methods for detection of anemia and ataxia
03/15/2005US6867016 Reagents and methods useful for detecting diseases of the gastrointestinal tract
03/15/2005US6867011 Synthetic bioepitope compounds which can be used as standards in the biological assays of Troponin I
03/15/2005US6867009 Nucleotide sequences coding polypeptide for use the treatment of neuropathic pain
03/15/2005US6867006 Use in stem cell mobilization, neuronal protection, and regulating hematopoiesis; inhibiting destruction of hematopoietic progenitor cells resulting from chemotherapy
03/15/2005US6867004 Monitoring monoclonal antibody reactivity to glycosylated fungal proteins; fungicides; immunoassays
03/15/2005US6866998 Cellular assays for identifying signaling peptides
03/15/2005US6866997 Designing a protein which is capable of binding to any predefined nucleic acid sequence
03/15/2005US6866991 Methods for promoting growth of bone, ligament, and cartilage using zvegf4
03/15/2005US6866855 Protein for use in the treatment and prevention of bacterial infections
03/15/2005US6866854 Spliced gene of KSHV/HHV8, its promoter and monoclonal antibodies specific for LANA2
03/15/2005US6866853 Engineering live attenuated viruses which contain a modified nonstructural gene segment; influenza vaccines
03/15/2005US6866852 Expression vector coding genetically engineered F protein of newcastle disease virus for developing poultry vaccine
03/15/2005US6866851 GFRα1-RET specific agonists and methods therefor
03/15/2005US6866848 Diagnosis and therapy of immune disorders induced by inhibitors of blood-coagulation factor VIII and inhibitors to binding of von Willebrand factor and/or membrane phosphatides
03/15/2005US6866845 Administering anti-C5a antibodies to treat blood and toxin disorders
03/15/2005US6866782 Process for the purification of pharmacologically active proteins through cationic exchange chromatography
03/15/2005CA2054325C Antisense oligonucleotides for treatment of cancer
03/15/2005CA1341476C Moleculary cloned acquired immunodeficiency syndrome polypeptides and their methods of use
03/10/2005WO2005022160A2 Diagnosis and treatment of micobacterial infections
03/10/2005WO2005021789A1 Polypeptides involved in fungal biofilm formation and polynucleotides encoding same and uses thereof
03/10/2005WO2005021777A2 Uses of spatial configuration to modulate protein function
03/10/2005WO2005021765A2 Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins
03/10/2005WO2005021760A1 Method of improving the viability and the fermentation capacity of baking yeasts under hyperosmotic stress and freezing stress conditions
03/10/2005WO2005021759A1 Plant vasculature modulating factor
03/10/2005WO2005021758A1 Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist
03/10/2005WO2005021757A1 Polypeptides and polynucleotides for use as a medicament
03/10/2005WO2005021756A1 Anti-angiogenic peptides from the n-terminus of endostatin
03/10/2005WO2005021739A1 ANTIBODY AGAINST Nox1 POLYPEPTIDE, METHOD OF DIAGNOSING CANCER WITH THE USE OF Nox1 GENE AND METHOD OF SCREENING CANCER GROWTH INHIBITOR
03/10/2005WO2005021736A1 A method for preparing t-20 peptide by high cell density cultivation of recombinant e. coli containing t-20 peptide coding gene
03/10/2005WO2005021724A2 Gp115: methods and compositions for treating cancer
03/10/2005WO2005021723A2 Nucleic acid molecules from rice controlling abiotic stress tolerance
03/10/2005WO2005021722A2 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB
03/10/2005WO2005021716A2 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders
03/10/2005WO2005021713A2 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
03/10/2005WO2005021710A2 Chimeric molecules and methods of use
03/10/2005WO2005021707A2 Severe acute respiratory syndrome dna vaccine compositions and methods of use
03/10/2005WO2005021595A1 Methods of antibody engineering using antibody display rules
03/10/2005WO2005021593A1 Fusion polypeptides, and use thereof in antivascular tumor therapy
03/10/2005WO2005021592A2 Enhancing the circulating half-life of interleukin-2 proteins
03/10/2005WO2005021591A1 Isolated berovin photoprotein and use thereof
03/10/2005WO2005021590A1 Promoter of the human fatp5 gene and uses
03/10/2005WO2005021589A1 Acid soluble proteins from micellar casein
03/10/2005WO2005021588A1 Gastric and prostate cancer associated antigens
03/10/2005WO2005021587A1 Novel storage protein - encoding gene and uses therefor
03/10/2005WO2005021586A2 Metabolic engineering of viomycin biosynthesis
03/10/2005WO2005021585A2 Axmi-003, a delta-endotoxin gene and methods for its use
03/10/2005WO2005021583A2 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β
03/10/2005WO2005021582A2 Methods for the early diagnosis of ovarian cancer
03/10/2005WO2005021578A2 A novel chimeric polypeptide and use thereof
03/10/2005WO2005021576A2 Methods for for modeling gpcrs and for producing ligand blocking and receptor activating antibodies for same
03/10/2005WO2005021574A2 Induction of antiviral neutralizing antibodies in humans and animals
03/10/2005WO2005021556A2 Modified protease inhibitors
03/10/2005WO2005021514A1 Novel unnatural histidine analog amino acid
03/10/2005WO2005021035A1 A bivalent vaccine against fmd, its preparation methods and applications
03/10/2005WO2005021034A2 Safe mutant viral vaccines
03/10/2005WO2005021025A2 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION
03/10/2005WO2005021022A2 Stable formulations of peptides
03/10/2005WO2005020934A2 Fsh glycosylation mutant
03/10/2005WO2005020889A2 Functional influenza virus-like particles (vlps)
03/10/2005WO2005020785A2 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
03/10/2005WO2005020683A1 Chimeric cancer models
03/10/2005WO2005003162A3 An endogenous peptide and active subfragments thereof
1 ... 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 ... 2916